🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to demonstrate, after 52 weeks of treatment, the n...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00449605
Treatments Being Tested
This is a multicenter randomized, double-blind, placebo- and active-control...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07-27
Trial ID
NCT02492763
Treatments Being Tested
27 Type 2 diabetic subjects (HbA1c 7.5 - 9.5%) currently treated with diet ...
Status
Completed
Location
Indiana Clinical Research Center
Start Date
2012-01
Trial ID
NCT01232946
Treatments Being Tested
The primary objective of this trial is to compare the reduction in mean gly...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00814294
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
Insulin is normally not bioavailable when taken through the oral route, as ...
Status
Suspended
Location
Karolinska Trial Alliance, Phase I Unit
Start Date
2009-09
Trial ID
NCT00990444
Treatments Being Tested
Primary Objective: To demonstrate the superiority of sotagliflozin 400 mil...
Status
Completed
Location
Investigational Site Number 8406028
Start Date
2017-09-15
Trial ID
NCT03285594
Treatments Being Tested
Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patient...
Status
Completed
Location
Research Site
Start Date
2015-05
Trial ID
NCT02429258
The study is being performed to determine whether sitagliptin, a dipeptidyl...
Status
Completed
Location
Medical College of Wisconsin
Start Date
2013-06
Trial ID
NCT01859793
Treatments Being Tested
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001